What is the address of SCHOON-MED?

The registered office of SCHOON-MED is located at Schoonstraat 163 box A, 9940 Evergem.

Is SCHOON-MED still active?

Yes. According to the CBE (24 September 2026) SCHOON-MED is active, legal situation “Normale toestand”, started on 16 April 2018.

Is SCHOON-MED registered on Peppol?

No, SCHOON-MED is currently not registered on the Peppol network.

What is the enterprise number of SCHOON-MED?

The enterprise number of SCHOON-MED is BE0694760718.

When was SCHOON-MED founded?

SCHOON-MED was founded on 16 April 2018.

Who are the directors of SCHOON-MED?

According to the 2025 annual accounts, the directors of SCHOON-MED are: Annelies Capiau, Isabelle Vanderstraeten.

Is SCHOON-MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 16 April 2018; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did SCHOON-MED make in 2025?

SCHOON-MED posted a profit after taxes of € 894 in financial year 2025.

What is the revenue of SCHOON-MED?

As a small company, SCHOON-MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 98,387.

SCHOON-MED (Private Limited) - Evergem - BE0694760718

Dossier SCHOON-MED, printed on 24 September 2026 from databakkes.be/en/0694760718/schoon-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

SCHOON-MED from Evergem, company number BE0694760718, closed financial year 2025 with a result of € 894 after tax. For that financial year SCHOON-MED recorded a gross margin of € 98,387 and equity of € 64,986. Compared with financial year 2024, the result moved from € 10,034 to € 894. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 28, 2025.

What it is worth Growing

€ 64,986

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 894

▼ 91% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 69,309

▲ 23% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 3,486.

People and assets in 2025

Vehicles and equipment

€ 2,074

▼ 42% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 16 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.1 million

▼ 5% vs 2024

€ 72,380 is repaid this year. At this pace the long-term loan is gone in ≈ 16 years.

Owed to suppliers

€ 711

▲ 276% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 111,309 Gross margin 2022: € 111,309 First fiscal year in the series	€ 100,458 Gross margin 2023: € 100,458 ▼ 10% vs 2022 (€ 111,309) Unfavourable step	€ 108,377 Gross margin 2024: € 108,377 ▲ 8% vs 2023 (€ 100,458) Favourable step	€ 98,387 Gross margin 2025: € 98,387 ▼ 9% vs 2024 (€ 108,377) Unfavourable step	▼ 9%
Profit after taxes	€ 3,901 Profit after taxes 2022: € 3,901 First fiscal year in the series	€ 3,066 Profit after taxes 2023: € 3,066 ▼ 21% vs 2022 (€ 3,901) Unfavourable step	€ 10,034 Profit after taxes 2024: € 10,034 ▲ 227% vs 2023 (€ 3,066) Favourable step	€ 894 Profit after taxes 2025: € 894 ▼ 91% vs 2024 (€ 10,034) Unfavourable step	▼ 91%
Equity	€ 50,992 Equity 2022: € 50,992 First fiscal year in the series	€ 54,058 Equity 2023: € 54,058 ▲ 6% vs 2022 (€ 50,992) Favourable step	€ 64,092 Equity 2024: € 64,092 ▲ 19% vs 2023 (€ 54,058) Favourable step	€ 64,986 Equity 2025: € 64,986 ▲ 1% vs 2024 (€ 64,092) Favourable step	▲ 1%
Total debts	€ 1,363,366 Total debts 2022: € 1,363,366 First fiscal year in the series	€ 1,292,484 Total debts 2023: € 1,292,484 ▼ 5% vs 2022 (€ 1,363,366) Favourable step	€ 1,215,618 Total debts 2024: € 1,215,618 ▼ 6% vs 2023 (€ 1,292,484) Favourable step	€ 1,150,356 Total debts 2025: € 1,150,356 ▼ 5% vs 2024 (€ 1,215,618) Favourable step	▼ 5%
Cash	€ 55,772 Cash 2022: € 55,772 First fiscal year in the series	€ 66,584 Cash 2023: € 66,584 ▲ 19% vs 2022 (€ 55,772) Favourable step	€ 56,338 Cash 2024: € 56,338 ▼ 15% vs 2023 (€ 66,584) Unfavourable step	€ 69,309 Cash 2025: € 69,309 ▲ 23% vs 2024 (€ 56,338) Favourable step	▲ 23%
Land & buildings	€ 1,308,670 Land & buildings 2022: € 1,308,670 First fiscal year in the series	€ 1,236,687 Land & buildings 2023: € 1,236,687 ▼ 6% vs 2022 (€ 1,308,670) Unchanged	€ 1,176,422 Land & buildings 2024: € 1,176,422 ▼ 5% vs 2023 (€ 1,236,687) Unchanged	€ 1,103,668 Land & buildings 2025: € 1,103,668 ▼ 6% vs 2024 (€ 1,176,422) Unchanged	▼ 6%
Retained profit	€ -10,508 Retained profit 2022: € -10,508 First fiscal year in the series	€ -7,442 Retained profit 2023: € -7,442 ▲ € 3,066 vs 2022 (€ -10,508) Favourable step	€ 2,592 Retained profit 2024: € 2,592 ▲ € 10,034 vs 2023 (€ -7,442) Favourable step	€ 3,486 Retained profit 2025: € 3,486 ▲ 35% vs 2024 (€ 2,592) Favourable step	▲ 35%
Bank debt	€ 1,362,953 Bank debt 2022: € 1,362,953 First fiscal year in the series	€ 1,292,484 Bank debt 2023: € 1,292,484 ▼ 5% vs 2022 (€ 1,362,953) Favourable step	€ 1,215,429 Bank debt 2024: € 1,215,429 ▼ 6% vs 2023 (€ 1,292,484) Favourable step	€ 1,149,645 Bank debt 2025: € 1,149,645 ▼ 5% vs 2024 (€ 1,215,429) Favourable step	▼ 5%
Balance sheet total	€ 1,414,358 Balance sheet total 2022: € 1,414,358 First fiscal year in the series	€ 1,346,542 Balance sheet total 2023: € 1,346,542 ▼ 5% vs 2022 (€ 1,414,358) Unchanged	€ 1,279,710 Balance sheet total 2024: € 1,279,710 ▼ 5% vs 2023 (€ 1,346,542) Unchanged	€ 1,215,342 Balance sheet total 2025: € 1,215,342 ▼ 5% vs 2024 (€ 1,279,710) Unchanged	▼ 5%

Key figures of SCHOON-MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to SCHOON-MED?

What happened at SCHOON-MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 28, 2025 New annual accounts for financial year 2025: profit of € 894 (▼ 91% vs 2024). Source: NBB ↗
Apr 16, 2018 New establishment in Evergem. KBO
2018 Annelies Capiau became a director. NBB
2018 Isabelle Vanderstraeten became a director. NBB
Apr 16, 2018 Start of the company according to the CBE. KBO

In short

From € 3,901 profit in 2022 to € 894 profit in 2025.

Paid € 225 in corporate taxes since 2022.

Best year ever: 2024, with € 10,034 profit.

Original PDFs at the National Bank ↗

A new publication or filing at SCHOON-MED? We notify you, reason included.

Follow SCHOON-MED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Annelies Capiau Isabelle Vanderstraeten

SCHOON-MED

DOKTER VANDERSTRAETEN ISABELLE HUISARTSENPRAKTIJK

Behind SCHOON-MED are Annelies Capiau and Isabelle Vanderstraeten. Isabelle Vanderstraeten is also behind DOKTER VANDERSTRAETEN ISABELLE HUISARTSENPRAKTIJK.

See the full network in the app

Directors

According to the 2025 annual accounts

Annelies Capiau

Director

since 2018

Isabelle Vanderstraeten

Director

Also active at: DOKTER VANDERSTRAETEN ISABELLE HUISARTSENPRAKTIJK

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Schoonstraat 163 box A

9940 Evergem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Huisarts Dr. Annelies Capiau

€ 69,962 gross margin · 2025

Dr. Sofie Demoen, Huisarts

€ 91,677 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0694.760.718
VAT number: BE 0694.760.718
Registered office: Schoonstraat 163 bus A, 9940 Evergem
Names & denominations: SCHOON-MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 16 April 2018
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗